Reltecimod
Product Specifications
CAS Number
1447799-33-8
Target
Immunology/Inflammation related|||Antibacterial
Related Pathways
Microbiology/Virology|||Immunology/Inflammation
Bioactivity
Reltecimod, a CD28 antigen inhibitor, is used potentially for the treatment of necrotizing soft tissue infection.
Smiles
C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N[C@@H](C(O)=O)C)=O)CC(O)=O)=O)=O)C)=O)C(C)C)=O)CC(C)C)=O)CCSC)(=O)[C@H]2N(C([C@@H](NC([C@@H](C)N)=O)CO)=O)CCC2
Molecular Formula
C46H72N10O15S
Molecular Weight
1037.19
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
D9901-50D-HRP 100 µL
Dynein 1, Cytoplasmic, Intermediate Chain 2 (Cytoplasmic Dynein 1 Intermediate Chain 2, DYNC1I2, Cytoplasmic Dynein Intermediate Chain 2, Dynein Intermediate Chain 2 Cytosolic, DH IC-2) (HRP) discontinued
Ask
View Details 
MBS1193369-01 0.02 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv.trifolii Hydroxyethylthiazole kinase (thiM)
Ask
View Details MBS1193369-02 0.02 mg (Yeast)
Recombinant Rhizobium leguminosarum bv.trifolii Hydroxyethylthiazole kinase (thiM)
Ask
View Details MBS1193369-03 0.1 mg (E-Coli)
Recombinant Rhizobium leguminosarum bv.trifolii Hydroxyethylthiazole kinase (thiM)
Ask
View Details